Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers
Status:
Completed
Trial end date:
2018-06-19
Target enrollment:
Participant gender:
Summary
The planned study is to determine the pharmacokinetic properties of Esketamine and safety
assessment with inhaled Esketamine after different number of inhalations and different dosing
sequences within three parts of the study.
Phase:
Phase 1
Details
Lead Sponsor:
Celon Pharma SA
Collaborators:
National Center for Research and Development, Poland The National Centre for Research and Development, Poland